Core Scientific [CORZZ] vs Oracle [ORCL] Detailed Stock Comparison

Core Scientific Inc.

NASDAQ
Loading...

Oracle Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Core Scientific Inc. wins in 2 metrics, Oracle Corporation wins in 11 metrics, with 1 ties. Oracle Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Core Scientific Inc. Oracle Corporation Better
P/E Ratio (TTM) N/A 31.65 N/A
Price-to-Book Ratio N/A 15.11 N/A
Debt-to-Equity Ratio -1.21 415.27 Oracle Corporation
PEG Ratio N/A 1.38 N/A
EV/EBITDA -10.96 23.16 Oracle Corporation
Profit Margin (TTM) -90.47% 25.30% Oracle Corporation
Operating Margin (TTM) -78.49% 32.68% Oracle Corporation
EBITDA Margin (TTM) N/A 32.68% N/A
Return on Equity 29.98% 57.57% Oracle Corporation
Return on Assets (TTM) -5.76% 6.34% Oracle Corporation
Free Cash Flow (TTM) $-460.96M $-394.00M Oracle Corporation
Dividend Yield N/A 1.01% N/A
1-Year Return 44.72% 36.40% Core Scientific Inc.
Price-to-Sales Ratio (TTM) 0.00 7.91 Tie
Enterprise Value $851.15M $635.53B Oracle Corporation
EV/Revenue Ratio 2.67 9.92 Core Scientific Inc.
Gross Profit Margin (TTM) 26.02% 64.56% Oracle Corporation
Revenue per Share (TTM) $1 $23 Oracle Corporation
Earnings per Share (Diluted) N/A $5.57 N/A
Beta (Stock Volatility) 6.36 1.60 Oracle Corporation
Short % of Float N/A 1.62% N/A

Core Scientific Inc. vs Oracle Corporation Stock Performance Analysis

Loading Price Chart...

CORZZ
ORCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Core Scientific Inc.89.70%89.70%89.70%88.23%76.79%82.67%
Oracle Corporation-5.83%20.62%27.76%54.57%10.88%17.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Core Scientific Inc.44.72%813.10%813.10%813.10%813.10%813.10%
Oracle Corporation36.40%113.22%172.39%477.44%598.36%1,495.62%

Performance & Financial Health Analysis: Core Scientific Inc. vs Oracle Corporation

MetricCORZZORCL
Market Information
Market Cap i$0$498.36B
Market Cap CategoryMicro capMega cap
10 Day Avg. Volume i15,48640,165,144
90 Day Avg. Volume i13,14628,439,468
Last Close$29.10$230.33
52 Week Range$10.96 - $29.62$134.57 - $345.72
% from 52W High-1.76%-33.38%
All-Time High$30.45 (Jun 02, 2026)$345.72 (Sep 10, 2025)
% from All-Time High-4.43%-33.38%
Growth Metrics
Quarterly Revenue Growth-0.16%0.22%
Quarterly Earnings Growth-0.16%0.27%
Financial Health
Profit Margin (TTM) i-0.90%0.25%
Operating Margin (TTM) i-0.78%0.33%
Return on Equity (TTM) i0.30%0.58%
Debt to Equity (MRQ) i-1.21415.27
Cash & Liquidity
Book Value per Share (MRQ)$-3.06$11.67
Cash per Share (MRQ)$0.99$13.61
Operating Cash Flow (TTM) i$278.25M$23.51B
Levered Free Cash Flow (TTM) i$-539,492,096$-22,298,499,072
Dividends
Last 12-Month Dividend Yield iN/A1.01%
Last 12-Month Dividend iN/A$2.00

Valuation & Enterprise Metrics Analysis: Core Scientific Inc. vs Oracle Corporation

MetricCORZZ (Apr 26, 2026)ORCL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A31.65
Forward P/E iN/A22.08
PEG Ratio iN/A1.38
Price to Sales (TTM) i0.007.91
Price to Book (MRQ) iN/A15.11
Market Capitalization
Market Capitalization i$0$498.36B
Enterprise Value i$851.15M$635.53B
Enterprise Value Metrics
Enterprise to Revenue i2.679.92
Enterprise to EBITDA i-10.9623.16
Risk & Other Metrics
Beta i6.361.60
Book Value per Share (MRQ) i$-3.06$11.67

Financial Statements Comparison: Core Scientific Inc. vs Oracle Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORZZ (2025)ORCL (2025)
Revenue/Sales i319.02M57.40B
Cost of Goods Sold i281.12M16.93B
COGS % of Revenue i88.1%29.5%
Gross Profit i37.90M40.47B
Gross Margin i11.9%70.5%
Research & Development iN/A9.86B
Operating Income (EBIT) i-224.55M18.05B
Operating Margin i-70.4%31.5%
EBITDA i-77.65M24.71B
EBITDA Margin i-24.3%43.1%
Pre-Tax Income i-288.03M14.16B
Pre-Tax Income % of Revenue i-90.3%24.7%
Income Tax i583,0001.72B
Income Tax % of Revenue i0.2%3.0%
Net Income (Profit) i-288.62M12.44B
Profit Margin i-90.5%21.7%

Balance Sheet & Liquidity Metrics

MetricCORZZ (2025)ORCL (2025)
Cash & Equivalents i311.38M10.79B
Total Current Assets i895.54M24.58B
Total Current Assets % of Revenue i280.7%42.8%
Total Current Liabilities i781.40M32.64B
Total Current Liabilities % of Revenue i244.9%56.9%
Long-Term Debt i1.15B96.83B
Long-Term Debt % of Revenue i360.5%168.7%
Total Shareholders Equity i-962.74M20.97B
Retained Earnings i-4.15B-15.48B
Retained Earnings % of Revenue i-1,299.8%-27.0%
Property, Plant & Equipment i599.46M0

Cash Flow Statement Comparison

MetricCORZZ (2025)ORCL (2025)
Operating Cash Flow i222.49M21.21B
Operating Cash Flow % of Revenue i69.7%37.0%
Capital Expenditures i-725.54MN/A
Free Cash Flow i-460.96M-394.00M
FCF Margin i-144.5%-0.7%
Debt Repayment i-10.29M-15.84B
Common Stock Repurchase iN/A-1.50B

Short Interest & Institutional Ownership Analysis

MetricCORZZORCL
Shares Short iN/A27.67M
Short Ratio iN/A1.00
Short % of Float iN/A1.62%
Shares Outstanding i314.23M2.88B
Float Shares i233.52M1.71B
% Held by Insiders iN/A40.55%
% Held by Institutions iN/A44.43%
% Held by Public iN/A15.02%

Dividend Analysis & Yield Comparison: Core Scientific Inc. vs Oracle Corporation

MetricCORZZORCL
Last 12-Month Dividend iN/A$2.00
Last 12-Month Dividend Yield iN/A1.01%
3-Year Avg Annual Dividend iN/A$1.73
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A$5.20
Ex-Dividend DateN/AJan 09, 2026